What It Takes to Win in the Healthtech Attention Economy in 2026

The number of healthtech startups competing for attention has grown dramatically over the last 15 years. Since 2011, the digital health ecosystem has raised more than $140 billion in the U.S., according to a 15-year lookback report from Rock Health. In Q3 2026 alone, digital health startups in the U.S. raised $3.7 billion across 114 deals. This comes as about half of U.S. adults own some form of health wearable and hype around AI’s potential in precision medicine and preventive healthcare has taken hold.

That AI hype cut both ways in 2026, because the incumbents bought into it too. The EHR vendors that once served as the integration point for AI partners started shipping AI of their own. Epic released its own ambient documentation tool in February, then used its August User Group Meeting to unveil Agent Factory. Ambient scribing, prior authorization checks, coding support and patient assistants, the categories that launched a generation of venture-backed startups, are now arriving as features inside a system hospitals already pay for.

That has forced a reckoning in how startups describe themselves. When a buyer’s default option is “wait for Epic’s version,” the claims that once set startups apart, like AI capabilities, workflow automation and seamless EHR integration, become table stakes. As a result, products were repositioned, pitches were rewritten, and many companies tried to be all things to everyone in the process.

To understand what it takes to stand out in a crowded field, we started with the companies actively seeking the spotlight. Of the over 1,600 companies that applied to speak at HLTH 2026, we selected 72 U.S.-based, venture-backed healthtech startups at Series A to Series C with 10 to 200 employees. That cohort has the funding to invest in its story but not yet the brand recognition to be heard by default, which is where messaging matters most. You can view our full methodology here.

Scoring the Story

Before we dive into the report, it’s essential to walk you through how we landed here.

The report, conducted in partnership between public relations agency SolComms and HLTH, Healthcare's #1 Innovation Event, gave each company a messaging score to measure the strength of the startup’s outward perception and assess how a buyer may perceive it. The score looked at four dimensions — clarity, differentiation, proof, and policy awareness — by analyzing the content and messaging on each startup’s website and social media. We then compared messaging scores with where and how often the company's mission showed up in owned, earned, and paid media across 75 outlets. Finally, the report includes insights from top-tier journalists who cover healthtech and leading venture capitalists on what makes them lean in and how to stand out in a crowded field.

The bottom line? A clear message doesn’t guarantee attention.

Clarity alone doesn’t earn attention

The correlation between a company's message score and the number of stories across owned, earned, and paid media was 0.09, or practically none. Clarity on its own fared only slightly better, at 0.14. A clear message doesn’t hurt a company’s coverage, but on its own it doesn’t win the story either.

The companies that earned the most coverage weren’t the best explainers. Doctronic earned 81 stories, the most of any company we tracked, including 23 in the highest-visibility outlets. Yet, its messaging score was 9 out of 20, with its messaging classified as “muddled.” Similarly, another newsworthy performer, b.well Connected Health, earned 43 stories with a messaging score of only 7 out of 20.

Meanwhile, Watershed Health was the only company to reach the top band on messaging, scoring 16 out of 20, but earned only five stories.

LinkedIn is the strongest signal

While companies, including healthtech, are hiring their own internal “storytellers” — often former journalists — to shape their reputation, the overwhelming conclusion is that strong messaging alone doesn’t seem to influence media coverage.

The strongest predictor of press coverage in our data wasn’t any messaging dimension. It was the size of a company’s LinkedIn following (correlation: 0.23). That’s still a modest relationship, but it points somewhere useful. Reporters notice companies and leaders who are already visible in the conversation. Executive presence, built consistently over time, appears to do more for coverage than polishing the homepage.

Presence vs. polish

While the media doesn’t always follow the clearest messaging, every investor surveyed rated a founder's ability to tell a compelling story as critical to funding decisions.

“I believe having a clear vision and strong POV for what you want to build is becoming even more important in the world of AI where you can more easily build,” says Mike Spadafore, a Managing Director of Valtruis.

Further, reporters shared with us that strong news hooks, evidence and data showing real-world impact, and clear market differentiation would make them lean in to learn more.

“A signal that tells me something new about where healthtech is going, and beyond the company or person the pitch is about. That signal could be clinical data, regulatory clearance, reimbursement, [or a] funding round,” says Anna O’Sullivan, who writes the FutureFemHealth newsletter.

The muddled middle

The “competent” and “muddled” messaging buckets are overflowing. The industry hasn't failed to communicate. But it has converged on average, semi-clear messaging.

The majority of healthtech companies analyzed fell within the middle of the pack when it came to messaging. Thirty-three companies received a messaging score of 11 to 15, falling in “competent,” while 35 scored between six and ten, falling in “muddled.”

Watershed Health was the lone “breakthrough,” scoring 16, while Aradigm was deemed invisible, scoring zero.

One VC surveyed said the landscape is moving so fast that it's less about clear messaging on past successes and more about a clear vision for how to integrate into real-world healthcare operations.

“AI-powered” doesn’t turn heads or write checks

We are in a period of “AI-powered” fatigue. Almost every founder believes that their elevator pitch should contain phrases like “AI-powered,” in the wake of “transforming the system.” However, overused jargon is not getting companies the platforms and attention they are hoping to get.

While nearly three-quarters, 72 percent, of the companies analyzed lead with "AI-powered,” not one VC surveyed said the phrase increases their confidence.

Reporters surveyed independently ranked "AI-powered" among the most overused phrases in pitches, alongside "revolutionizing/transforming" and "disrupting."

Policy is being sidestepped

Health policy drives a lot of these companies, and yet, few signal policy literacy. Only 10 of 70 homepages reference any of the 11 core policy terms and topics tracked, including FDA, ACA, drug pricing, and MAHA.

It’s an area that shows potential for healthtech startups to stand out. Reporters surveyed named policy and regulatory angles as one of the story formats that drives the most reader engagement.

Investors notice when it’s missing. Regulatory pathway clarity was among the founder claims VCs surveyed said most often turn out to be overstated or misleading. Emma Silverman, Partner at TMV, puts the stakes plainly: “This is not an industry where you can play it fast and loose, and founders who don’t understand that will struggle to land partners in healthcare and, worse, make costly and dangerous mistakes.”

What this means for healthtech leaders

​​The data points to a split audience. The story that raises capital and the story that earns coverage are not the same.

Investors reward a clear, compelling story: every investor we surveyed called it critical to funding decisions. Reporters reward signals: data, regulatory milestones, reimbursement wins, and policy relevance. Few companies deliver both, and most have settled into middle-of-the-pack messaging that serves neither audience well.

Three shifts can help close that gap:

• Build presence before you need it: LinkedIn following was the strongest predictor of coverage in our data. Executives who show up consistently with a point of view, not just company news, are the ones reporters already know when a story breaks.
• Treat policy as an opening, not a risk: Only 10 of 70 homepages referenced a core policy topic, yet reporters named policy and regulatory angles among the most engaging story formats. A clear stance on how your company fits into FDA oversight, drug pricing, or the MAHA agenda shows the rigor investors look for and gives reporters a hook.
• Lead with proof, not adjectives: With incumbents like Epic shipping AI natively, “AI-powered” won’t separate anyone. Clinical data, reimbursement wins, regulatory milestones, and customer outcomes will.

The companies that hold attention will pair a clear point of view on where they fit in real-world healthcare with steady proof that they’re delivering on it.